Future of AVF in Hemodialysis Patients at the Donka National Hemodialysis Center

Introduction: Hemodialysis is one of the substitute treatment modalities of replacement therapy for renal failure, it requires vascular access capable of delivering a blood flow between 200 to 600 ml/min.An arteriovenous fistula is an opening obtained by the surgical creation of an anastomosis between an artery and a juxtaposed vein.The objective of our study was to assess the survival and fate of AVF in hemodialysis patients at the Donka National Hemodialysis Center. Material and Methods:This was a prospective, descriptive study lasting 15 months, taking into account all AVFs created between 2018 and 2019 at the CNHD.Were included in our study, all chronic hemodialysis patients with AVF, who agreed to participate in the study, with informed consent at the Donka National Hemodialysis Center.Results: On 90 chronic hemodialysis patients on AVF, we obtained an AVF frequency of 65.22%.We found a male predominance which represented 55 cases, or 61%, the most affected age group was 29 to 38 years with 26 cases, or 28.89%.Multiple hematoma was the problem with the AVF puncture in 30% of cases.The dominant complication was aneurysm 54,4%, the outcome of AVF was 92%. Conclusion:arteriovenous fistula is a vascular approach which dominates a better quality of life, it can progress to complications which require efficient diagnostic means.